Research and development of therapeutic effectors targeting β1,4-galactosyltransferase7 (Q3697467)

From EU Knowledge Graph
Revision as of 17:16, 24 November 2021 by DG Regio (talk | contribs) (‎Changed an Item: Edited by the beneficiary bot - attach the beneficiary based on the string)
Jump to navigation Jump to search
Project Q3697467 in France
Language Label Description Also known as
English
Research and development of therapeutic effectors targeting β1,4-galactosyltransferase7
Project Q3697467 in France

    Statements

    0 references
    12,000.0 Euro
    0 references
    24,000.0 Euro
    0 references
    50.0 percent
    0 references
    1 January 2015
    0 references
    31 December 2016
    0 references
    Université de Lorraine
    0 references
    0 references
    Le projet vise à concevoir, développer et cribler des molécules à visée régénératrice et thérapeutique ciblant spécifiquement la β4GalT7 (French)
    0 references
    The project aims to design, develop and screen regenerative and therapeutic molecules specifically targeting β4GalT7 (English)
    22 November 2021
    0 references

    Identifiers

    LO0006448
    0 references